Physician profile
Sharon Rice
NPI 1790761401
$450.34
in general payments reported to CMS, 2019-2025
13 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.55 · 2023: $93.35 · 2024: $99.54 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $387.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $94.79 | 2019-2024 | |
| Coopersurgical, INC. | $94.52 | 2023-2025 | Paragard T 380a, Endosee |
| Sumitomo Pharma America, INC. | $59.68 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $41.50 | 2025 | Thinprep 2000 Processor, Aptima |
| Astellas Pharma US INC | $28.02 | 2024 | Veozah |
| Sage Therapeutics, LLC | $23.31 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $20.45 | 2024 | |
| Pfizer INC. | $20.14 | 2024 | |
| Amgen INC. | $17.99 | 2025 | Evenity, Prolia |
| Therapeuticsmd, INC. | $14.20 | 2019 | |
| Evofem Biosciences, INC. | $13.17 | 2025 | Phexxi, Solosec, Phexx |
| Amag Pharmaceuticals, INC. | $12.32 | 2019 | |
| Organon LLC | $10.25 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.